GIM
AHCO icon

Glenmede Investment Management’s AdaptHealth AHCO Stock Holding History

Glenmede Investment Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$310K Buy
34,662
+735
+2% +$6.81K ﹤0.01% 1112
2025
Q2 		$320K Buy
+33,927
New +$299K ﹤0.01% 1086

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Investment Management's AHCO Position: Q3 2025 in Review

Glenmede Investment Management increased its AdaptHealth (AHCO) stake by 2.2% in Q3 2025, buying an estimated $6.81K and bringing the position to 34,662 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Glenmede Investment Management first reported a position in AHCO in Q2 2025 and has held it in 2 quarters since. The position peaked at $320K in Q2 2025. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

  • Glenmede Investment Management held 34,662 shares of AdaptHealth worth $310K as of Q3 2025.
  • Glenmede Investment Management bought 735 AdaptHealth shares in Q3 2025, an estimated $6.81K.
  • AdaptHealth made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1112 holding.
  • Glenmede Investment Management first reported a position in AdaptHealth in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's AdaptHealth position peaked at $320K in Q2 2025.
  • 225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.